BTG Has The Firepower For Its Next Steps In Interventional Med

UK-listed BTG PLC shares the UK life science industry's concerns about long-term negative fallout from Brexit, but it finds itself in a relatively comfortable position. The acquisitive interventional medicines company says it has plenty of firepower for more M&A.

More from Growth

More from In Vivo